COVID-19 VACCINE DEVELOPMENT PRESS

Director of LPPOM MUI Muti Arintawati (right) provides a press information about the development of COVID-19 vaccines in the Ministry of Health Building, Jakarta, Monday (19/10/2020). The Ministry of Health reveals three COVID-19 vaccines from Sinovac, Sinopharm, and Cansino from China has completed a phase III clinical trial in several countries and plans at the end of November 2020 can be done for 9.1 million people in Indonesia. ANTARA PHOTO/Indrianto Eko Suwarso/nz